Medtronic PLC MDT
88.64
0.13
0.15%
as of 25 Sep
- Market cap
- $112.2B
- P/E
- 21.7×
Follow MDT
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Medtronic PLC (MDT) Revenue
Medtronic PLC's revenue for fiscal 2026 was $36.4B, up 8.43% from $33.5B in fiscal 2025. Over the twelve months to 31 July 2026 it was $37.5B. Over the past ten years it has ranged from $20.3B (fiscal 2015) to $36.4B (fiscal 2026) — the current reading is the highest in ten years. Revenue has risen for 3 consecutive fiscal years. Medtronic PLC ranks 2nd of 140 Medical Devices companies by revenue.
Revenue, annual
Annual
| Period | Revenue | Change |
|---|---|---|
| FY2026 | $36.4B | 8.43% |
| FY2025 | $33.5B | 3.62% |
| FY2024 | $32.4B | 3.64% |
| FY2023 | $31.2B | (1.45%) |
| FY2022 | $31.7B | 5.21% |
| FY2021 | $30.1B | 4.16% |
| FY2020 | $28.9B | (5.38%) |
| FY2019 | $30.6B | 2.02% |
| FY2018 | $30.0B | 0.82% |
| FY2017 | $29.7B | 3.04% |
Quarterly
| Period | Revenue | Change |
|---|---|---|
| Jul 2026 | $9.8B | (0.53%) |
| Apr 2026 | $9.8B | 8.77% |
| Jan 2026 | $9.0B | 0.62% |
| Oct 2025 | $9.0B | 4.46% |
| 43 more quarters | Free account |
Against its own ten years
Low $20.3B
High $36.4B
Ten-year median
$30.3B
Current reading's percentile
100
Revenue against peers
| Company | Revenue |
|---|---|
| ABT Abbott Laboratories compare | $46.6B |
| MDT Medtronic PLC | $37.5B |
| SYK Stryker Corporation compare | $25.8B |
| GEHC GE HealthCare Technologies Inc. compare | $21.3B |
| BSX Boston Scientific Corporation compare | $21.0B |
| PHG Koninklijke Philips N.V. compare | $20.6B |
| EW Edwards Lifesciences Corporation compare | $6.5B |
| STE STERIS plc compare | $6.0B |
| DXCM DexCom, Inc. compare | $5.0B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on MDT
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement